Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 63187-812

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 63187-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)
Chemical structure of Cyclobenzaprine hydrochloride, showing its core molecular framework and hydrochloride component as part of the compound.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)
A data table presenting the frequency of adverse effects including drowsiness, dry mouth, fatigue, and headache in clinical trial groups comparing Cyclobenzaprine HCl tablets at 5 mg and 10 mg dosages with a placebo group. Sample sizes are 464 for 5 mg, 249 for 10 mg, and 469 for placebo.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)
A data table comparing the incidence of side effects—drowsiness, dry mouth, and dizziness—reported in clinical studies versus a surveillance program for Cyclobenzaprine hydrochloride 10 mg tablets. Percentages are shown for each side effect in both study types.*
FDA Label Image

63187-812-07 (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 05)

63187-812-07 (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 05)
Label for Cyclobenzaprine Hydrochloride 10 mg film-coated tablets by Proficient Rx LP. The bottle contains 120 round, biconvex tablets debossed with '1G' and '283'. Manufactured by InvaGen Pharmaceuticals, a Cipla Ltd subsidiary, with storage instructions at 20°-25°C. The label includes NDC 63187-812 and states the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.